Primary pathogens (Staphylococcus aureus (MSSA) · group B Streptococcus · Escherichia coli and other Enterobacteriaceae · anaerobes (Bacteroides, Clostridium) in necrotizing soft-tissue infection)
Clinical context (Neonatal necrotizing phlegmon / necrotizing soft-tissue infection — rapidly progressive deep soft-tissue infection in infants ≤28 days; may complicate omphalitis, umbilical infection, pustulosis, or postoperative wound infection · surgical emergency)
First-line therapy
Oxacillin • i.v. • 25–50 mg/kg/dose • 4×/day
Max 2000 mg/dose · Max 12000 mg/day · Duration: 10–14 days · Antistaphylococcal penicillin for MSSA — nafcillin is an equivalent alternative per local formulary
• Oxacillin frequency in neonates is NOT QID by default — interval lengthens with lower GA and younger PNA: ≤34 weeks PNA 0–7 days 25 mg/kg q12h; >34 weeks PNA 0–28 days 25 mg/kg q8h; PNA >28 days 25 mg/kg q6h (Nelson's Pediatric Antimicrobial Therapy, ILPQC NICU table). Calculator uses 25 mg/kg q6h as term-neonate fallback; severe MSSA may require 50 mg/kg/dose — consult pharmacy.
• Gentamicin: NOT divided QID in neonates — use extended-interval dosing by GA/PNA (Red Book/Nelson): GA <30 weeks PNA ≤14 days 5 mg/kg q48h; GA 30–34 weeks PNA ≤10 days 5 mg/kg q36h; GA ≥35 weeks PNA ≤7 days 4 mg/kg q24h; GA ≥35 weeks PNA 8–60 days 5 mg/kg q24h. Calculator fallback 5 mg/kg once daily for term neonate — verify interval with NICU protocol and TDM.
• Antibiotics alone are insufficient — urgent surgical debridement within hours is mandatory; antibiotic therapy without debridement is associated with near-100% mortality in neonatal necrotizing fasciitis (EAST NSTI PMTG, neonatal NF literature).
• Empiric regimen must cover Gram-positive cocci (S. aureus including MRSA risk, GBS), Gram-negative bacilli, and anaerobes — add metronidazole or clindamycin for suspected necrotizing infection; tailor after cultures at 48–72 h (StatPearls omphalitis, IDSA SSTI/NSTI principles).
• Do not delay antibiotics or surgery for stable sampling — obtain blood, wound, and surgical tissue cultures when feasible before first dose, but proceed immediately if child is septic or deteriorating (SIS/IDSA stewardship principles).
Enter weight on Kids to calculate doses
Gentamicin • i.v./i.m. • 5–5 mg/kg/dose • 1×/day
Max 80 mg/dose · Duration: 10–14 days · Extended-interval aminoglycoside — dose and interval vary by GA/PNA (see high-dose indications); monitor levels if therapy >48–72 h
Max 500 mg/dose · Duration: 10–14 days · Anaerobic coverage — add when foul discharge, crepitus, or necrotizing infection suspected; clindamycin alternative for toxin suppression (StatPearls omphalitis, IDSA NSTI principles)
Enter weight on Kids to calculate doses
Ampicillin • i.v. • 50–50 mg/kg/dose • 3×/day
Max 2000 mg/dose · Max 8000 mg/day · Duration: 10–14 days · Neonatal non-meningitis dosing — interval q8h–q12h by GA/PNA; PNA >28 days may use q6h (Nelson's, Red Book)
• Ampicillin + gentamicin: preferred over ampicillin/sulbactam in neonates — broader neonatal sepsis coverage (GBS, Listeria, enteric Gram-negatives) with established NICU dosing; amp-sulb has limited sulbactam PK/safety data in neonates (Nelson's, Red Book, UTMB neonatal manual).
• Ampicillin + gentamicin: alternative when oxacillin unavailable or when GBS/enteric Gram-negative coverage prioritized over narrow MSSA focus — switch to oxacillin/nafcillin or vancomycin when MRSA suspected (AAP Red Book, neonatal sepsis principles).
• Clindamycin + gentamicin: suspected group A streptococcal or clostridial necrotizing infection — clindamycin inhibits toxin production per CDC GAS necrotizing fasciitis guidance; does not reliably cover all enteric Gram-negatives alone.
• Ampicillin/sulbactam is NOT first-line in neonates for this indication — use ampicillin + gentamicin or oxacillin-based regimens; reserve amp-sulb for older infants only per local NICU/surgery protocol.
• Add metronidazole (or clindamycin) for anaerobic coverage in all suspected necrotizing neonatal soft-tissue infections — foul discharge, crepitus, skin necrosis, or rapid progression (StatPearls omphalitis, IDSA NSTI principles).
Enter weight on Kids to calculate doses
Gentamicin • i.v./i.m. • 5–5 mg/kg/dose • 1×/day
Max 80 mg/dose · Duration: 10–14 days · Same GA/PNA-based extended-interval dosing as first-line gentamicin tier
Max 500 mg/dose · Duration: 10–14 days · Anaerobic coverage when necrotizing infection or foul umbilical discharge — clindamycin alternative
Enter weight on Kids to calculate doses
Clinical notes
• Recognition at primary level: rapidly spreading erythema, swelling, disproportionate pain, fever/hypothermia, lethargy, poor feeding — may follow omphalitis or umbilical infection; high toxicity suggests neonatal necrotizing soft-tissue infection.
• Primary care ABCDE: airway/breathing support; IV access; aggressive fluid resuscitation if septic; analgesia; temperature control; obtain blood cultures when feasible but do NOT delay antibiotics or transfer.
• Urgent actions: start IV antibiotics immediately per local neonatal protocol; emergent pediatric surgery consult — surgical debridement within hours is mandatory; antibiotics alone are insufficient.
• Early diagnosis: maintain high index of suspicion in any neonate with rapidly spreading erythema, disproportionate pain, bullae, crepitus, skin necrosis, or failure to improve within 24–48 h of IV antibiotics — may follow omphalitis or appear without obvious umbilical infection (StatPearls, neonatal NF case series).
• Urgent surgical debridement: emergent pediatric surgery consultation and operative exploration within hours — not optional; serial re-debridement at 24 h is often required; delay beyond 24 h increases mortality (EAST NSTI practice management guideline, IDSA/CDC NSTI principles).
• AAP Red Book — Neonatal sepsis, omphalitis, and staphylococcal infections (2024)
